JLHL

Jupiter Life Line Hospitals Limited

Multi-specialty hospitals under Jupiter Hospitals brand

Healthcare›Healthcare›Healthcare Services›Hospital

jupiterhospital.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹247.05
Market cap
8,095 Cr
Stock P/E
43.1
P/B
5.25
Dividend yield
0.1%
ROE (FY26)
12.6%
ROCE (FY26)
14.5%
Operating margin (FY26)
17.0%
Debt / equity (FY26)
0.33
OCF / EBITDA (FY26)
78.0%
OCF / EBITDA (3Y)
72.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Jupiter Life Line Hospitals (Jupiter Hospitals) runs hospitals in Thane, Pune, Indore and Dombivli and says its focus for new hospitals remains Western India.

Company snapshot

14thBy market cap

Ranked among 24 companies in Hospital.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales263 Cr273 Cr290 Cr287 Cr323 Cr321 Cr327 Cr348 Cr394 Cr365 Cr388 Cr411 Cr
Operating expenses (approx.)202 Cr211 Cr228 Cr223 Cr248 Cr246 Cr248 Cr270 Cr301 Cr282 Cr299 Cr332 Cr
EBITDA61 Cr62 Cr62 Cr64 Cr75 Cr75 Cr78 Cr78 Cr92 Cr83 Cr89 Cr79 Cr
OPM %23.2%22.7%21.4%22.2%23.2%23.4%24.0%22.5%23.4%22.8%23.0%19.3%
Other income4 Cr8 Cr9 Cr8 Cr9 Cr8 Cr7 Cr13 Cr11 Cr9 Cr9 Cr11 Cr
Interest12 Cr1 Cr0.93 Cr1 Cr1 Cr3 Cr6 Cr8 Cr8 Cr8 Cr9 Cr13 Cr
Depreciation11 Cr11 Cr10 Cr11 Cr14 Cr14 Cr18 Cr21 Cr21 Cr22 Cr23 Cr26 Cr
Profit before tax41 Cr58 Cr62 Cr60 Cr69 Cr67 Cr62 Cr62 Cr74 Cr57 Cr66 Cr51 Cr
Tax %18.6%24.8%27.2%25.8%25.3%21.1%27.7%28.7%22.6%25.3%26.2%25.8%
Net profit34 Cr44 Cr45 Cr45 Cr52 Cr53 Cr45 Cr44 Cr57 Cr42 Cr49 Cr38 Cr
EPS (₹)₹5.67₹6.56₹6.49₹6.80₹7.86₹8.01₹6.84₹6.69₹8.75₹6.49₹7.66₹5.72

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales486 Cr733 Cr893 Cr1,070 Cr1,262 Cr1,500 CrSign in free for the trailing twelve months
Operating expenses (approx.)419 Cr580 Cr691 Cr831 Cr965 Cr1,157 CrSign in free for the trailing twelve months
EBITDA67 Cr153 Cr201 Cr238 Cr297 Cr343 CrSign in free for the trailing twelve months
OPM %13.8%20.9%22.6%22.3%23.5%22.9%Sign in free for the trailing twelve months
Other income4 Cr4 Cr10 Cr26 Cr29 Cr42 CrSign in free for the trailing twelve months
Interest39 Cr44 Cr42 Cr26 Cr11 Cr33 CrSign in free for the trailing twelve months
Depreciation31 Cr36 Cr39 Cr42 Cr57 Cr88 CrSign in free for the trailing twelve months
Profit before tax2 Cr77 Cr129 Cr195 Cr258 Cr265 CrSign in free for the trailing twelve months
Tax %247.7%33.7%43.4%9.6%24.9%25.0%Sign in free for the trailing twelve months
Net profit-2 Cr51 Cr73 Cr177 Cr194 Cr199 CrSign in free for the trailing twelve months
EPS (₹)₹-0.45₹10.05₹13.95₹28.65₹29.47₹29.59Sign in free for the trailing twelve months
Dividend payout %———3.2%3.4%3.3%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital51 Cr51 Cr57 Cr66 Cr66 Cr66 Cr
Reserves188 Cr243 Cr309 Cr1,103 Cr1,291 Cr1,479 Cr
Borrowings426 Cr495 Cr469 Cr—326 Cr509 Cr
Other liabilities117 Cr125 Cr153 Cr113 Cr223 Cr331 Cr
Total liabilities789 Cr909 Cr986 Cr1,281 Cr1,905 Cr2,383 Cr
Fixed assets (net)629 Cr683 Cr719 Cr716 Cr973 Cr1,376 Cr
CWIP26 Cr27 Cr29 Cr74 Cr185 Cr129 Cr
Investments7 Cr3 Cr2 Cr17 Cr114 Cr486 Cr
Loans & advances———0.55 Cr0 Cr0 Cr
Inventories13 Cr15 Cr19 Cr21 Cr24 Cr38 Cr
Trade receivables22 Cr28 Cr46 Cr57 Cr42 Cr76 Cr
Cash & bank19 Cr103 Cr134 Cr301 Cr368 Cr55 Cr
Other assets72 Cr50 Cr37 Cr94 Cr198 Cr224 Cr
Total assets789 Cr909 Cr986 Cr1,281 Cr1,905 Cr2,383 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity123 Cr137 Cr176 Cr115 Cr253 Cr268 Cr
Cash from investing-296 Cr-85 Cr-94 Cr-76 Cr-209 Cr-442 Cr
Cash from financing184 Cr32 Cr-51 Cr128 Cr301 Cr136 Cr
Net cash flow12 Cr84 Cr31 Cr167 Cr345 Cr-38 Cr
Free cash flow (OCF − Capex)-118 Cr46 Cr100 Cr29 Cr-67 Cr-234 Cr

Ratios

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %6.0%15.4%20.5%19.0%15.9%14.5%
ROE %-0.9%17.7%20.0%15.1%14.2%12.6%
Debtor days161419201218
Inventory days1088779
Days payable443029213023
Cash conversion cycle-18-9-26-114
OCF / EBITDA %183.7%89.3%87.6%48.1%85.4%78.0%
OCF / EBITDA % (3 years)——103.5%72.2%73.9%72.4%
Debt / equity1.781.721.29—0.240.33
Current ratio1.181.461.583.874.513.02
Net debt / EBITDA6.052.551.66-1.26-0.141.32